Annual Total Expenses
$275.57 M
-$23.70 M-7.92%
December 31, 2023
Summary
- As of February 8, 2025, KPTI annual total expenses is $275.57 million, with the most recent change of -$23.70 million (-7.92%) on December 31, 2023.
- During the last 3 years, KPTI annual total expenses has fallen by -$4.36 million (-1.56%).
- KPTI annual total expenses is now -10.55% below its all-time high of $308.09 million, reached on December 31, 2021.
Performance
KPTI Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Expenses
$65.07 M
-$5.84 M-8.24%
September 30, 2024
Summary
- As of February 8, 2025, KPTI quarterly total expenses is $65.07 million, with the most recent change of -$5.84 million (-8.24%) on September 30, 2024.
- Over the past year, KPTI quarterly total expenses has dropped by -$5.84 million (-8.24%).
- KPTI quarterly total expenses is now -21.22% below its all-time high of $82.59 million, reached on June 30, 2022.
Performance
KPTI Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Expenses Formula
Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses
KPTI Total Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -7.9% | -8.2% |
| 3 y3 years | -1.6% | -20.2% |
| 5 y5 years | +31.1% | +23.8% |
KPTI Total Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -10.6% | at low | -21.2% | at low |
| 5 y | 5-year | -10.6% | +19.7% | -21.2% | +6.0% |
| alltime | all time | -10.6% | +2533.8% | -21.2% | +1673.4% |
Karyopharm Therapeutics Total Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $65.07 M(-8.2%) |
| Jun 2024 | - | $70.91 M(+6.0%) |
| Mar 2024 | - | $66.89 M(-6.5%) |
| Dec 2023 | $275.57 M(-7.9%) | $71.56 M(+6.4%) |
| Sep 2023 | - | $67.27 M(+0.2%) |
| Jun 2023 | - | $67.15 M(-3.5%) |
| Mar 2023 | - | $69.60 M(+3.2%) |
| Dec 2022 | $299.28 M(-2.9%) | $67.45 M(+0.7%) |
| Sep 2022 | - | $66.98 M(-18.9%) |
| Jun 2022 | - | $82.59 M(+0.4%) |
| Mar 2022 | - | $82.26 M(+3.7%) |
| Dec 2021 | $308.09 M(+10.1%) | $79.31 M(-2.7%) |
| Sep 2021 | - | $81.50 M(+13.8%) |
| Jun 2021 | - | $71.65 M(-5.3%) |
| Mar 2021 | - | $75.63 M(+4.8%) |
| Dec 2020 | $279.94 M(+21.6%) | $72.17 M(+5.4%) |
| Sep 2020 | - | $68.44 M(-7.3%) |
| Jun 2020 | - | $73.83 M(+12.7%) |
| Mar 2020 | - | $65.49 M(+6.7%) |
| Dec 2019 | $230.17 M(+9.5%) | $61.36 M(+16.8%) |
| Sep 2019 | - | $52.55 M(+2.7%) |
| Jun 2019 | - | $51.18 M(-21.4%) |
| Mar 2019 | - | $65.08 M(+12.9%) |
| Dec 2018 | $210.22 M | $57.66 M(+16.7%) |
| Sep 2018 | - | $49.39 M(-8.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2018 | - | $54.22 M(+10.8%) |
| Mar 2018 | - | $48.94 M(+19.4%) |
| Dec 2017 | $132.14 M(+19.2%) | $40.99 M(+32.0%) |
| Sep 2017 | - | $31.05 M(+4.4%) |
| Jun 2017 | - | $29.75 M(-2.0%) |
| Mar 2017 | - | $30.35 M(+11.5%) |
| Dec 2016 | $110.89 M(-7.1%) | $27.21 M(+5.5%) |
| Sep 2016 | - | $25.79 M(-15.5%) |
| Jun 2016 | - | $30.54 M(+11.6%) |
| Mar 2016 | - | $27.35 M(-6.7%) |
| Dec 2015 | $119.33 M(+56.9%) | $29.33 M(-4.4%) |
| Sep 2015 | - | $30.68 M(-7.5%) |
| Jun 2015 | - | $33.16 M(+26.8%) |
| Mar 2015 | - | $26.15 M(+0.7%) |
| Dec 2014 | $76.08 M(+121.6%) | $25.96 M(+31.3%) |
| Sep 2014 | - | $19.77 M(+20.0%) |
| Jun 2014 | - | $16.47 M(+18.6%) |
| Mar 2014 | - | $13.88 M(+14.1%) |
| Dec 2013 | $34.34 M(+107.8%) | $12.17 M(+30.6%) |
| Sep 2013 | - | $9.32 M(+33.1%) |
| Jun 2013 | - | $7.00 M(+19.8%) |
| Mar 2013 | - | $5.84 M(+36.8%) |
| Dec 2012 | $16.52 M(+57.9%) | $4.27 M(+16.4%) |
| Sep 2012 | - | $3.67 M |
| Dec 2011 | $10.46 M | - |
FAQ
- What is Karyopharm Therapeutics annual total expenses?
- What is the all time high annual total expenses for Karyopharm Therapeutics?
- What is Karyopharm Therapeutics annual total expenses year-on-year change?
- What is Karyopharm Therapeutics quarterly total expenses?
- What is the all time high quarterly total expenses for Karyopharm Therapeutics?
- What is Karyopharm Therapeutics quarterly total expenses year-on-year change?
What is Karyopharm Therapeutics annual total expenses?
The current annual total expenses of KPTI is $275.57 M
What is the all time high annual total expenses for Karyopharm Therapeutics?
Karyopharm Therapeutics all-time high annual total expenses is $308.09 M
What is Karyopharm Therapeutics annual total expenses year-on-year change?
Over the past year, KPTI annual total expenses has changed by -$23.70 M (-7.92%)
What is Karyopharm Therapeutics quarterly total expenses?
The current quarterly total expenses of KPTI is $65.07 M
What is the all time high quarterly total expenses for Karyopharm Therapeutics?
Karyopharm Therapeutics all-time high quarterly total expenses is $82.59 M
What is Karyopharm Therapeutics quarterly total expenses year-on-year change?
Over the past year, KPTI quarterly total expenses has changed by -$5.84 M (-8.24%)